federal_register: 2012-25741
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts | regulation_id_numbers |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2012-25741 | Endocrinologic and Metabolic Drugs Advisory Committee; Amendment of Notice | Notice | 2012-10-19 | 2012 | 10 | https://www.federalregister.gov/documents/2012/10/19/2012-25741/endocrinologic-and-metabolic-drugs-advisory-committee-amendment-of-notice | https://www.govinfo.gov/content/pkg/FR-2012-10-19/pdf/2012-25741.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 |